1. Home
  2. MYGN vs STC Comparison

MYGN vs STC Comparison

Compare MYGN & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.74

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Stewart Information Services Corporation

STC

Stewart Information Services Corporation

HOLD

Current Price

$64.10

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
STC
Founded
1991
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
2.1B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
MYGN
STC
Price
$4.74
$64.10
Analyst Decision
Buy
Buy
Analyst Count
8
3
Target Price
$7.64
$81.33
AVG Volume (30 Days)
1.6M
160.8K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
3.23%
EPS Growth
N/A
55.17
EPS
N/A
4.05
Revenue
$771,400,000.00
$2,921,636,000.00
Revenue This Year
$7.19
$13.62
Revenue Next Year
$5.64
$7.13
P/E Ratio
N/A
$16.05
Revenue Growth
2.33
17.32
52 Week Low
$3.76
$56.39
52 Week High
$10.30
$78.61

Technical Indicators

Market Signals
Indicator
MYGN
STC
Relative Strength Index (RSI) 43.84 39.73
Support Level $3.93 $59.36
Resistance Level $5.63 $64.35
Average True Range (ATR) 0.35 1.92
MACD 0.01 -0.37
Stochastic Oscillator 30.77 22.81

Price Performance

Historical Comparison
MYGN
STC

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: